📉 Numbers dekho, bhai!
Artemis Medicare Services ne Q3 FY26 ke results reveal kiye hain, aur numbers sach mein solid hain. Consolidated revenue pichle saal ke comparison mein 17.2% jump karke ₹272 crore tak pahunch gaya hai. Company ke core specialties aur high-value procedures mein badhotri iska main reason hai. Quarter mein EBITDA ₹52 crore raha aur PAT 7.9% badhkar ₹22 crore ho gaya.
Pichle 9 mahine ki baat karein toh revenue ₹802 crore ho gaya hai, jo 15.1% zyada hai pichle saal se. EBITDA bhi ₹159 crore raha, jismein margin 19.8% ka raha.
Expansion ka bada plan aur funding ka jugaad
Ab sabse interesting part! Company ka goal hai ki 2029 tak apni bed capacity ko 700-800 beds se badha kar 2,000-2,300 beds tak le jaaye. Is massively ambitious expansion ke liye, Artemis Medicare ₹700 crore ka fund raise karne ki planning kar rahi hai, jo Qualified Institutional Placement (QIP) ya preferential allotment ke through ho sakta hai. Is fund se new hospital projects aur organic expansion ko boost milega, aur target hai ki net debt ko ₹250-280 crore tak control mein rakha jaaye.
Strategy aur Future Outlook
Company ka strategy hai ki low-margin government business ko kam karke profitability badhai jaaye. International patients se revenue 34.9% badha hai aur ab total revenue ka 34% contribute kar raha hai, jo medical tourism mein unki strength dikhata hai. Management AI-assisted triage jaise digital transformation par bhi focus kar raha hai. Raipur mein naya hospital April-May 2026 mein khulne ki ummeed hai, aur South Delhi mein bhi ek naya hospital aayega. Investors ab dekhenge ki company apne ₹700 crore ke fund ko kaise use karti hai aur EBITDA margins ko kaise improve karti hai.